Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)
... a selective serotonin and norepinephrine dual
reuptake inhibitor approved for the management of ... that, in-vitro, preferentially blocks the
reuptake of norepinephrine with higher potency than ... is a selective serotonin and norepinephrine
reuptake inhibitor (SNRI), similar to some drugs used ...
Forest and Cypress Announce FDA Approval of Savella(TM) for the Management of Fibromyalgia
... a selective serotonin and norepinephrine dual
reuptake inhibitor, was approved by the U.S. Food and Drug ... be central to fibromyalgia. Savella blocks the
reuptake of both norepinephrine and serotonin, with greater selectivity for the inhibition of norepinephrine
reuptake in vitro. This may be the mechanism by which ...
Zogenix and Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved Sumavel(TM) DosePro(TM)
... and is not generally recommended for use with selective serotonin
reuptake inhibitors (SSRIs), serotonin-norepinephrine
reuptake inhibitors SNRIs or MAO inhibitors. Sumavel DosePro should be used ...
Surveyed Psychiatrists and PCPs Expect to Increase Their First-Line Use of SNRIs Over the Next Two Years for the Treatment of Generalized Anxiety Disorder
... physicians (PCPs) expect to increase their use of serotonin-norepinephrine
reuptake inhibitors (SNRIs) over the next two years for the treatment of ... claims data show that benzodiazepines and selective serotonin
reuptake inhibitors (SSRIs) dominate early lines of treatment. However, the ...
Results of phase III study on Labopharm's novel antidepressant published in Psychiatry (Edgemont) Journal
... treated with two different types of drug therapy: selective serotonin
reuptake inhibitors (SSRIs) or serotonin-norepinephrine
reuptake inhibitors (SNRIs)). However, some 40 to 50% of patients being treated for ...
New Once-Daily RYZOLT(TM) (tramadol HCl extended-release tablets) Now Available in the U.S.
... analgesic that binds to the mu -opioid receptor and also inhibits the
reuptake of both serotonin and norepinephrine. Taken once every 24 hours, RYZOLT ... increases the seizure risk in patients taking selective serotonin
reuptake inhibitors (SSRI antidepressants or anorectics), tricyclic antidepressants ...
FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
... or NMS-like reactions have been reported with serotonin-norepinephrine
reuptake inhibitors (SNRIs) and selective serotonin
reuptake inhibitors (SSRIs) alone, including Symbyax treatment, but particularly ...
AstraZeneca Licenses Novel Antidepressant Compounds Discovered by Mayo Clinic and Virginia Tech Collaboration
... announced that AstraZeneca has licensed a portfolio of preclinical Triple
reuptake Inhibitor (TRI) compounds for depression. Researchers at Virginia Tech ... as selective serotonin (SSRI) and dual serotonin/norepinephrine (SNRI)
reuptake inhibitors are proven treatments for depression and anxiety. However, they ...
SSRI Antidepressants May Lower Adult Suicide Risk
... say
TUESDAY, Feb. 3 (HealthDay News) -- Selective serotonin
reuptake inhibitors (SSRIs) may significantly reduce the risk of attempted or ... observational studies should reassure doctors that prescribing serotonin
reuptake inhibitors in patients with major depression is safe," but children and ...
Certain Antidepressants Ease Fibromyalgia Symptoms
... Journal of the American Medical Association . Serotonin and noradrenaline
reuptake inhibitors helped with those three symptoms but to a much lesser extent, while selective serotonin
reuptake inhibitors and monoamine oxidase inhibitors helped lessen pain some.
...
Labopharm to host webcast presentation on novel trazodone formulation - tomorrow (Dec.16/08) at 10:00 a.m. ET
... once-daily formulation of trazodone (DDS-04A), a serotonin antagonist
reuptake inhibitor (SARI), for the treatment of major depressive disorder.
The ... of 150 mg and 300 mg of trazodone hydrochloride, a serotonin antagonist
reuptake inhibitor (SARI), for the treatment of major depressive disorder (MDD) to ...
Labopharm to host webcast presentation on novel trazodone formulation for treatment of major depressive disorder
... once-daily formulation of trazodone (DDS-04A), a serotonin antagonist
reuptake inhibitor (SARI), for the treatment of major depressive disorder.
The ... of 150 mg and 300 mg of trazodone hydrochloride, a serotonin antagonist
reuptake inhibitor (SARI), for the treatment of major depressive disorder (MDD) to ...
Labopharm's NDA for Novel Trazodone Formulation accepted for review by FDA
... once-daily formulation of trazodone (DDS-04A), a serotonin antagonist
reuptake inhibitor (SARI), for the treatment of major depressive disorder, has been ... of 150 mg and 300 mg of trazodone hydrochloride, a serotonin antagonist
reuptake inhibitor (SARI), for the treatment of major depressive disorder (MDD) to ...
Labopharm Reports Results for Third Quarter Fiscal 2008
... Drug Administration (FDA) for DDS-04A, a once-daily
serotonin antagonist
reuptake inhibitor (SARI) that provides an effective
option in the treatment of ... ----------------------------------------------- (1) Serotonin Antagonist
reuptake Inhibitor. (2) Includes France, Germany, the United Kingdom, Spain and ...
New Webcast Going for Gold to Educate on Importance of Healthy Diet In Persistent Chronic Pain Management
... life-threatening
condition when taken together with selective serotonin
reuptake inhibitors
(SSRIs), serotonin norepinephrine
reuptake inhibitors (SNRIs), monoamine
oxidase inhibitors (MAOIs), tricyclic ...
Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder
... of a class of drugs commonly referred to as
serotonin and noradrenaline
reuptake inhibitors,(12) is already approved by
the EMEA to treat major depressive ... cord. Based on pre-clinical studies, duloxetine is a balanced and
potent
reuptake inhibitor of serotonin and norepinephrine/noradrenaline.
Scientists ...
Video: Olympic Games Gold Medalist Nikki Stone Joins Chronic Pain Experts in Educational Webcasts
... life-threatening
condition when taken together with selective serotonin
reuptake inhibitors
(SSRIs), serotonin norepinephrine
reuptake inhibitors (SNRIs), monoamine
oxidase inhibitors (MAOIs), tricyclic ...
Do antidepressants enhance immune function?
... and studied the ex vivo effects of three drugs, a selective serotonin
reuptake inhibitor (SSRI), a substance P antagonist, and a glucocorticoid ... cell function in HIV infection may be enhanced by selective serotonin
reuptake inhibition and also by substance P antagonism in both depressed and ...
Seven Clinical Presentations on Tapentadol Immediate Release for Acute Pain to Be Featured at 2008 American Pain Society Annual Meeting
... of action, combining mu-opioid
receptor agonism and norepinephrine
reuptake inhibition in a single
molecule. It is being developed in ... at parts of the brain that control how pain
is perceived. Norepinephrine
reuptake inhibitors are a type of central
nervous system medication that increases ...
Treating SSRI-resistant depression
... disorder that do not respond to treatment with a selective serotonin
reuptake inhibitor (SSRI) antidepressant: either switching to a second SSRI or to a ... this project, explains the results: Switching from a selective serotonin
reuptake inhibitor to a drug with a different mechanism of action was found to be ...
XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
... with the in-licensing of
Bicifadine, a serotonin and norepinephrine
reuptake inhibitor for the
treatment of diabetic neuropathic pain, in January 2007, ... pain and HCV. XTL is
developing Bicifadine, a serotonin and norepinephrine
reuptake inhibitor,
for the treatment of diabetic neuropathic pain, which is ...
New Hope for Depressed Teens
... respond to treatment with antidepressants known as selective serotonin
reuptake inhibitors (SSRIs).
Guidelines recommend prescribing SSRI medications, ... plus cognitive behavioral therapy; Effexor (a serotonin-norepinephrine
reuptake inhibitor, or SNRI); or Effexor plus cognitive behavioral therapy.
...
Comparison of venlafaxine and SSRIs in the treatment of depression
... popular classes of antidepressants, the newer serotonin and norepinephrine
reuptake inhibitors (SNRIs), like venlafaxine (Effexor), and the older selective serotonin
reuptake inhibitors (SSRIs), like fluoxetine (Prozac) and citalopram (Celexa), to ...
New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets
... of action, combining mu-opioid
receptor agonism and norepinephrine
reuptake inhibition in a single
molecule. It is being developed in ... at parts of the brain that control how pain is perceived.
Norepinephrine
reuptake inhibitors are a type of central nervous system
medication that increase ...
FDA approves ABILIFY(R) (aripiprazole) as the first medication for add-on treatment of MDD
... one of the commonly prescribed ADTs, including selective serotonin
reuptake inhibitors (SSRIs): Lexapro(R) (escitalopram), Prozac(R) (fluoxetine), ... controlled-release), Zoloft(R) (sertraline); or a serotonin-norepinephrine
reuptake inhibitor (SNRI): Effexor XR(R) (venlafaxine extended release). The ...
Genes Might Predispose Antidepressant Users to Suicidal Thoughts
... (FDA) recommended that the class of drugs known as selective serotonin
reuptake inhibitors (SSRIs) carry a strong "black box" warning on the label ... either an SSRI or another type of drug, a serontonin-norepinephrine
reuptake inhibitor (SNRI) to help treat depression, anxiety disorders, and other ...
Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
... its side effect profile as a member of the serotonin
agonist and serotonin
reuptake inhibitor (SARI) class of antidepressants.
The use of existing ... anti-depressant that acts as a dual serotonin
agonist and serotonin
reuptake inhibitor (SARI). Trazodone appears to
increase serotonin activity via ...
Depression Poses Pregnancy Risks
... birth defects.
Other reports have found that babies born to women who are taking a type of antidepressant known as an SSRI (selective serotonin
reuptake inhibitor) could have breathing or feeding problems, according to the March of Dimes.
The bulletin recommends that treatment with antidepressants ...
World's First Deep Brain Stimulation Device Approved for Treatment of Psychiatric Condition in Europe
... for OCD in Western
Europe. Patients with severe OCD, as defined by a Y-BOCS score over 30, and
who have tried at least three selective serotonin
reuptake inhibitors (SSRIs)
without treatment success, may be considered eligible for Reclaim DBS therapy.
The neurostimulators used for Reclaim DBS ...
Lilly Resubmits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
... be a major cause of work absenteeism, underemployment and unemployment.
About Cymbalta
Based on preclinical studies, Cymbalta is a potent
reuptake inhibitor of serotonin and norepinephrine. Although the exact way that Cymbalta works in people is unknown, it is believed to be related to an ...
Celexa May Not Help Kids With Autism
... neurologist and director of medical autism research at the Kennedy Krieger Institute in Baltimore.
Antidepressants known as selective serotonin
reuptake inhibitors, or SSRIs, are a common treatment for autism and given to perhaps 30 percent of children with the condition, said Dr. Bryan King, lead ...
Depression Treatment Wanes Following FDA Warnings
... finds.
Researchers at the University of Colorado say the U.S. Food and Drug Administration's advisories about the use of selective serotonin
reuptake inhibitors (SSRIs) appear to be associated with "unintended" and "persistent" changes in the diagnosis and treatment of depression, especially in ...
Some Antidepressants May Thwart Tamoxifen's Effect on Breast Cancer
... tamoxifen to reduce their odds for recurrence. But tamoxifen often causes hot flashes, a side effect that can be controlled with selective serotonin
reuptake inhibitor (SSRI) antidepressants such as paroxetine (Paxil) or fluoxetine (Prozac). Besides working on the neurotransmitter serotonin, these drugs ...
Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association
... 14 patients with a DSM-IV diagnosis of treatment resistant obsessive compulsive disorder (OCD) and under stable treatment with selective serotonin
reuptake inhibitors (SSRIs) and neuroleptic augmentation, aimed to evaluate the potential of ondansetron augmentation as an alternative treatment for OCD.
...
Wayne K. Goodman, MD, Renowned Expert on Obsessive Compulsive Disorder, Joins Mount Sinai as Chair of Psychiatry
... is the principal developer of Y-BOCS, the rating gold standard for OCD, and he conducted some of the first controlled trials of selective serotonin
reuptake inhibitors. Dr. Goodman was the co-founder of the Obsessive Compulsive Foundation, which is the major consumer advocacy organization for OCD, and ...
Are we cherry picking participants for studies of antidepressants?
... additional illnesses or conditions.
After assessing 2,855 patients treated with citalopram, a commonly prescribed selective serotonin
reuptake inhibitor for mood disorders, study authors concluded that fewer than one in four, or 22.2 percent, of the patients met the usual criteria for ...
Forest Laboratories, Inc. Reports Fiscal Year 2009 Fourth Quarter Reported EPS of $0.31 Including $0.45 Per Share Charge Related to the Ongoing United States Attorney's Office Investigation
... as significant expenses associated with the launch of Bystolic and pre-launch spending for Savella(TM), a selective serotonin norepinephrine dual
reuptake inhibitor (SNRI) indicated for the management of fibromyalgia that was approved in January. Excluding the USAO investigation charge, SG&A ...
Aplenzin(TM), the Only Single Tablet Once-Daily Treatment for Depression at All Doses, Now Available in the United States
... however, it is believed that bupropion, the active ingredient of Aplenzin, may help restore the balance of neurotransmitters, by inhibiting the
reuptake of norepinephrine and dopamine.
Aplenzin was approved by the U.S. Food and Drug Administration (FDA) in April 2008. Sanofi-aventis U.S., which ...
New P.E. Drug Approved In Europe While Premature Ejaculation Cure Remains Out of Reach to American Men
... mood and mental faculties, promoting proper nervous system function and helps prolong orgasm.
Dapoxetine is among a class of selective serotonin
reuptake inhibitor (SSRI) drugs that include antidepressants which are widely used to stimulate production of serotonin to last longer in bed. Major drug ...
Task Force Recommends Screening Adolescents for Clinical Depression
... of life, especially if they have a family history of depression."
There is adequate evidence that treating adolescents with selective serotonin
reuptake inhibitors (SSRIs), psychotherapy or combined therapy (SSRIs and psychotherapy) result in decreased clinical depression symptoms. Treating ...